title: Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.
authors.affiliation: Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Khorana
authors.forename: H-M
authors.initials: HM
authors.lastname: Otten
authors.forename: J I
authors.initials: JI
authors.lastname: Zwicker
authors.forename: G C
authors.initials: GC
authors.lastname: Connolly
authors.forename: D F
authors.initials: DF
authors.lastname: Bancel
authors.forename: I
authors.initials: I
authors.lastname: Pabinger
mesh_terms: D000553:Ambulatory Care / Q000592:standards*; D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D003661:Decision Support Techniques; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors